BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17379503)

  • 1. Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer.
    Vazquez-Martin A; Colomer R; Menendez JA
    Eur J Cancer; 2007 May; 43(7):1117-24. PubMed ID: 17379503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Her-2/neu-induced "cytokine signature" in breast cancer.
    Vazquez-Martin A; Colomer R; Menendez JA
    Adv Exp Med Biol; 2008; 617():311-9. PubMed ID: 18497054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genomic explanation connecting "Mediterranean diet", olive oil and cancer: oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA3 DNA binding site" complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells.
    Menendez JA; Papadimitropoulou A; Vellon L; Lupu R
    Eur J Cancer; 2006 Oct; 42(15):2425-32. PubMed ID: 16406575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarrays.
    Menendez JA; Vazquez-Martin A; Oliveras-Ferraros C; Garcia-Villalba R; Carrasco-Pancorbo A; Fernandez-Gutierrez A; Segura-Carretero A
    Int J Mol Med; 2008 Oct; 22(4):433-9. PubMed ID: 18813848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1.
    Lattrich C; Juhasz-Boess I; Ortmann O; Treeck O
    Oncol Rep; 2008 Mar; 19(3):811-7. PubMed ID: 18288420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of early placenta insulin-like growth factor in breast cancer cells provides an autocrine loop that predominantly enhances invasiveness and motility.
    Brandt B; Kemming D; Packeisen J; Simon R; Helms M; Feldmann U; Matuschek A; Kersting C; Hinrichs B; Bidart JM; Bellet D; Bartkowiak K; Dankbar N; Dittmar T; Sauter G; Boecker W; Buerger H
    Endocr Relat Cancer; 2005 Dec; 12(4):823-37. PubMed ID: 16322324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2 regulatory control of angiopoietin-2 in breast cancer.
    Carter WB; Ward MD
    Surgery; 2000 Aug; 128(2):153-8. PubMed ID: 10922985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells.
    Chang CJ; Chiu JH; Tseng LM; Chang CH; Chien TM; Wu CW; Lui WY
    Eur J Clin Invest; 2006 Aug; 36(8):588-96. PubMed ID: 16893382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of interleukin-1 on cytokine gene expression by human corneal epithelial cells.
    Narayanan S; Glasser A; Hu YS; McDermott AM
    Exp Eye Res; 2005 Feb; 80(2):175-83. PubMed ID: 15670796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells.
    Kumar R; Mandal M; Lipton A; Harvey H; Thompson CB
    Clin Cancer Res; 1996 Jul; 2(7):1215-9. PubMed ID: 9816290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cloning and expression of the HER2 gene in MCF-7 cells].
    Li R; Zheng H; Luo RC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1264-7. PubMed ID: 16234104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells.
    Simeone AM; Nieves-Alicea R; McMurtry VC; Colella S; Krahe R; Tari AM
    Int J Oncol; 2007 Apr; 30(4):785-92. PubMed ID: 17332916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic and therapeutic role of HER2 in cancer.
    Ménard S; Pupa SM; Campiglio M; Tagliabue E
    Oncogene; 2003 Sep; 22(42):6570-8. PubMed ID: 14528282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype.
    Duan Z; Feller AJ; Penson RT; Chabner BA; Seiden MV
    Clin Cancer Res; 1999 Nov; 5(11):3445-53. PubMed ID: 10589757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH; Lin CC; Lin JK; Chen WJ
    J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2.
    Menendez JA; Vazquez-Martin A; Oliveras-Ferraros C; Garcia-Villalba R; Carrasco-Pancorbo A; Fernandez-Gutierrez A; Segura-Carretero A
    Int J Oncol; 2009 Jan; 34(1):43-51. PubMed ID: 19082476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
    Fujii T; Kawahara A; Basaki Y; Hattori S; Nakashima K; Nakano K; Shirouzu K; Kohno K; Yanagawa T; Yamana H; Nishio K; Ono M; Kuwano M; Kage M
    Cancer Res; 2008 Mar; 68(5):1504-12. PubMed ID: 18316615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel proximity assay for the detection of proteins and protein complexes: quantitation of HER1 and HER2 total protein expression and homodimerization in formalin-fixed, paraffin-embedded cell lines and breast cancer tissue.
    Shi Y; Huang W; Tan Y; Jin X; Dua R; Penuel E; Mukherjee A; Sperinde J; Pannu H; Chenna A; DeFazio-Eli L; Pidaparthi S; Badal Y; Wallweber G; Chen L; Williams S; Tahir H; Larson J; Goodman L; Whitcomb J; Petropoulos C; Winslow J
    Diagn Mol Pathol; 2009 Mar; 18(1):11-21. PubMed ID: 19214113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of HER2-induced endothelial cell retraction.
    Carter WB; Niu G; Ward MD; Small G; Hahn JE; Muffly BJ
    Ann Surg Oncol; 2007 Oct; 14(10):2971-8. PubMed ID: 17593333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro demonstration of breast cancer tumor cell sub-populations based on interleukin-1/tumor necrosis factor induction of interleukin-8 expression.
    Pantschenko AG; Pushkar I; Miller LJ; Wang YP; Anderson K; Peled Z; Kurtzman SH; Kreutzer DL
    Oncol Rep; 2003; 10(4):1011-7. PubMed ID: 12792762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.